Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Benefit From Combined Administration of Oral and Intravenous Nutrition - Enriched With Omega-3 Fatty Acids - for Intensive Care Patient

NCT01162928 is registered in ClinicalTrials.gov with B. Braun Melsungen AG as lead sponsor.

NCT NCT01162928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01162928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Benefit From Combined Administration of Oral and Intravenous Nutrition - Enriched With Omega-3 Fatty Acids - for Intensive Care Patient
Lead sponsor
B. Braun Melsungen AG
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2013
Completion date
November 30, 2017
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness